M. A. L, J. O, and L. L. T, “THE INCIDENCE OF DYSLIPIDEMIA AND DIABETES MELLITUS TYPE 2 AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS USING THE FIRST LINE HIGHLY ACTIVE ANTIRETRO-VIRAL THERAPY FOR AT LEAST TWELVE MONTHS IN SOUTHERN PHILIPPINES HIV-AIDS CORE TEAM HUB”, J ASEAN Fed Endocr Soc, vol. 34, p. 17, Jul. 2019.